# Dysregulated post-translational modifications in granulosa cells drive ovarian dysfunction and potential infertility applications (Review)

**Authors:** Yufei Zhong, Yunfei Zou, Zhuoyuan Yang, Junjun Wang, Zezheng Pan, Jiugeng Feng

PMC · DOI: 10.3892/ijmm.2026.5767 · 2026-02-16

## TL;DR

This review explores how changes in protein modifications in granulosa cells affect ovarian function and infertility.

## Contribution

The paper highlights novel PTMs like SUMOylation and lactylation in granulosa cells and their role in infertility.

## Key findings

- PTMs regulate granulosa cell proliferation, differentiation, and apoptosis.
- Aberrant PTMs impair follicular development and contribute to infertility.
- Targeting PTM-regulated signaling may offer new infertility treatments.

## Abstract

Ovarian granulosa cells (GCs), as key components of follicles, orchestrate follicular development and ovarian maturation through bidirectional communication with oocytes and through hormone synthesis. Their dysfunction substantially contributes to female infertility. Post-translational modifications (PTMs) carry out pivotal roles in the regulation of ovarian physiology and pathology by modulating GC proliferation, differentiation, apoptosis and steroid hormone secretion. The present review seeks to summarize the current advances in canonical PTMs such as phosphorylation, methylation, acetylation and ubiquitination, as well as novel protein modifications such as SUMOylation and lactylation, particularly focusing on their roles in the proliferation, differentiation and apoptosis of GCs at the molecular level. Moreover, the present review explores how aberrant PTMs impair GC function, leading to follicular developmental disorders, and proposes that targeting PTM-regulated signaling in GCs may provide novel therapeutic strategies for ovarian dysfunction. Collectively, the present review aims to provide insights into elucidating the etiology of infertility, and establishing a theoretical foundation for the development of PTM-targeted reproductive interventions.

## Full-text entities

- **Genes:** PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051] {aka C/EBP-beta, IL6DBP, NF-IL6, TCF5}, SMAD3 (SMAD family member 3) [NCBI Gene 4088] {aka HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3}, PTPRU (protein tyrosine phosphatase receptor type U) [NCBI Gene 10076] {aka FMI, PCP-2, PTP, PTP-J, PTP-PI, PTP-RO}, PGK1 (phosphoglycerate kinase 1) [NCBI Gene 5230] {aka HEL-S-68p, MIG10, PGKA}, NEDD4L (NEDD4 like E3 ubiquitin protein ligase) [NCBI Gene 23327] {aka NEDD4-2, NEDD4.2, PVNH7, RSP5, hNEDD4-2}, OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) [NCBI Gene 8473] {aka HINCUT-1, HRNT1, MRX106, O-GLCNAC, OGT1, XLID106}, MIR574 (microRNA 574) [NCBI Gene 693159] {aka MIR574-3p, MIRN574, hsa-mir-574, mir-574}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, DNMT1 (DNA methyltransferase 1) [NCBI Gene 1786] {aka ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT}, CYP19A1 (cytochrome P450 family 19 subfamily A member 1) [NCBI Gene 1588] {aka ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX}, PGC (progastricsin) [NCBI Gene 5225] {aka PEPC, PGII}, CRY1 (cryptochrome circadian regulator 1) [NCBI Gene 1407] {aka DSPD, PHLL1}, DNMT3A (DNA methyltransferase 3 alpha) [NCBI Gene 1788] {aka DNMT3A2, HESJAS, M.HsaIIIA, TBRS}, PTPN22 (protein tyrosine phosphatase non-receptor type 22) [NCBI Gene 26191] {aka LYP, LYP1, LYP2, PEP, PTPN22.5, PTPN22.6}, RUNX1 (RUNX family transcription factor 1) [NCBI Gene 861] {aka AML1, AML1-EVI-1, AMLCR1, CBF2alpha, CBFA2, EVI-1}, CDKN1B (cyclin dependent kinase inhibitor 1B) [NCBI Gene 1027] {aka CDKN4, KIP1, MEN1B, MEN4, P27KIP1}, USP7 (ubiquitin specific peptidase 7) [NCBI Gene 7874] {aka C16DELp13.2, DEL16P13.2, HAFOUS, HAUSP, TEF1}, ANXA2 (annexin A2) [NCBI Gene 302] {aka ANX2, ANX2L4, CAL1H, HEL-S-270, LIP2, LPC2}, AREG (amphiregulin) [NCBI Gene 374] {aka AR, AREGB, CRDGF, SDGF}, BCL2L11 (BCL2 like 11) [NCBI Gene 10018] {aka BAM, BIM, BOD}, STAR (steroidogenic acute regulatory protein) [NCBI Gene 6770] {aka STARD1}, SMAD4 (SMAD family member 4) [NCBI Gene 4089] {aka DPC4, JIP, MADH4, MYHRS}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, Egfr (epidermal growth factor receptor) [NCBI Gene 13649] {aka 9030024J15Rik, Erbb, Errb1, Errp, Wa5, wa-2}, IL31RA (interleukin 31 receptor A) [NCBI Gene 133396] {aka CRL, CRL3, GLM-R, GLMR, GPL, IL-31RA}, Sesn2 (sestrin 2) [NCBI Gene 230784] {aka HI95, SEST2, Ses2}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, LIPE (lipase E, hormone sensitive type) [NCBI Gene 3991] {aka AOMS4, FPLD6, HSL, LHS, REH}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, ACAT1 (acetyl-CoA acetyltransferase 1) [NCBI Gene 38] {aka ACAT, MAT, T2, THIL}, XRCC6 (X-ray repair cross complementing 6) [NCBI Gene 2547] {aka CTC75, CTCBF, G22P1, KU70, ML8, TLAA}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, FGF9 (fibroblast growth factor 9) [NCBI Gene 2254] {aka FGF-9, GAF, HBFG-9, HBGF-9, SYNS3}, IFI27 (interferon alpha inducible protein 27) [NCBI Gene 3429] {aka FAM14D, ISG12, ISG12A, P27}, PRMT5 (protein arginine methyltransferase 5) [NCBI Gene 10419] {aka HRMT1L5, HSL7, IBP72, JBP1, SKB1, SKB1Hs}, RPL11 (ribosomal protein L11) [NCBI Gene 6135] {aka DBA7, GIG34, L11, uL5}, SKP2 (S-phase kinase associated protein 2) [NCBI Gene 6502] {aka FBL1, FBXL1, FLB1, p45}, USP13 (ubiquitin specific peptidase 13) [NCBI Gene 8975] {aka ISOT3, IsoT-3}, OGA (O-GlcNAcase) [NCBI Gene 10724] {aka MEA5, MGEA5, NCOAT}, DDB1 (damage specific DNA binding protein 1) [NCBI Gene 1642] {aka DDBA, UV-DDB1, WHIKERS, XAP1, XPCE, XPE}, PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 5563] {aka AMPK, AMPK2, AMPKa2, PRKAA}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, SYVN1 (synoviolin 1) [NCBI Gene 84447] {aka DER3, HRD1}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, BBC3 (BCL2 binding component 3) [NCBI Gene 27113] {aka JFY-1, JFY1, PUMA}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, CITED4 (Cbp/p300 interacting transactivator with ED-rich tail 4) [NCBI Gene 163732], Glp1r (glucagon-like peptide 1 receptor) [NCBI Gene 14652] {aka GLP-1R, GLP1Rc}, MUL1 (mitochondrial E3 ubiquitin protein ligase 1) [NCBI Gene 79594] {aka C1orf166, GIDE, MAPL, MULAN, RNF218}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, H2BC21 (H2B clustered histone 21) [NCBI Gene 8349] {aka GL105, H2B, H2B-GL105, H2B.1, H2BE, H2BFQ}, RNF168 (ring finger protein 168) [NCBI Gene 165918] {aka RIDL, hRNF168}, CXXC1 (CXXC finger protein 1) [NCBI Gene 30827] {aka 2410002I16Rik, 5830420C16Rik, CFP1, CGBP, HsT2645, PCCX1}, COX1 (cytochrome c oxidase subunit I) [NCBI Gene 4512] {aka COI, MTCO1}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, FOXO3 (forkhead box O3) [NCBI Gene 2309] {aka AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A}, Gcg (glucagon) [NCBI Gene 14526] {aka GLP-1, Glu, PPG}
- **Diseases:** disorders (MESH:D009358), aneuploidy (MESH:D000782), hypoxia (MESH:D000860), reproductive diseases (MESH:D060737), imprinting disorders (MESH:C567357), ovarian diseases (MESH:D010049), ovarian inflammatory (MESH:D010051), pregnancy loss (MESH:D000022), hypoxic (MESH:D002534), OHSS (MESH:D016471), IVF (MESH:C537182), meiotic (MESH:D004314), abortion (MESH:D000026), tumor (MESH:D009369), Infertility (MESH:D007246), PCOS (MESH:D011085), female infertility (MESH:D007247), mitochondrial dysfunction (MESH:D028361), follicular atresia (MESH:D005497), endometriosis (MESH:D004715), GCs (MESH:D006106), POF (MESH:D016649), inflammatory (MESH:D007249)
- **Chemicals:** glucose (MESH:D005947), cholesterol (MESH:D002784), Myo-Inositol (MESH:D007294), threonine (MESH:D013912), CE (MESH:D002563), NA (MESH:C013147), ceramide (MESH:D002518), cAMP (MESH:D000242), crotonyl-CoA (MESH:C010701), ROS (MESH:D017382), lysine (MESH:D008239), NAD+ (MESH:D009243), sphingolipid (MESH:D013107), P4 (MESH:C015586), MLN4924 (MESH:C539933), Progesterone (MESH:D011374), LH (MESH:D007986), PA (MESH:D019308), lipid (MESH:D008055), iron (MESH:D007501), PGE2 (MESH:D015232), PAP (MESH:D010724), butyric acid (MESH:D020148), steroid (MESH:D013256), serine (MESH:D012694), CoA (MESH:D003065), cholesterol ester (MESH:D002788), tricarboxylic acid (MESH:D014233), rapamycin (MESH:D020123), nicotine (MESH:D009538), succinyl-CoA (MESH:C012046), lactate (MESH:D019344), E2 (MESH:D004958), amino acid (MESH:D000596), K (MESH:D011188), ISRIB (-), H2O2 (MESH:D006861), melatonin (MESH:D008550)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** granulosa cell tumor cell line — Bos taurus (Bovine), Spontaneously immortalized cell line (CVCL_6572), KGN — Homo sapiens (Human), Ovarian granulosa cell tumor, Cancer cell line (CVCL_0375)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12923276/full.md

---
Source: https://tomesphere.com/paper/PMC12923276